Bihua Chen, 10% Owner at MoonLake Immunotherapeutics (MLTX), bought 1,590,500 shares at $21.08 ($32.2M) on 2023-03-20, disclosed to the SEC on 2023-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.36 | 446,881 | $8.7M | 26.8% |
| 2 | $19.36 | 446,881 | $8.7M | 26.8% |
| 3 | $20.42 | 63,700 | $1.3M | 4.0% |
| 4 | $21.08 | 78,008 | $1.6M | 5.1% |
| 5 | $21.08 | 78,008 | $1.6M | 5.1% |
| 6 | $21.70 | 238,511 |
| $5.2M |
| 16.1% |
| 7 | $21.70 | 238,511 | $5.2M | 16.1% |
| Total | $20.27 avg | 1,590,500 | $32.2M | 100% |
| Filing → |
| CRBP | SELL | 2025-12-15 | $688K | — | Filing → |
| AARD | BUY | 2025-02-19 | $3.0M | — | Filing → |
| BIOA | BUY | 2024-10-01 | $8.1M | — | Filing → |